SUBMAXILLARY GLAND ENLARGEMENT

This adverse event was reported 72 times

SUBMAXILLARY GLAND ENLARGEMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEPOTASTINE BESILATE 1 0.0016
1 IOPROMIDE 3 0.0007
2 GATIFLOXACIN 1 0.0006
3 DAPRODUSTAT 1 0.0005
4 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
5 BARICITINIB 1 0.0003
6 INFLIXIMAB-DYYB 1 0.0003
7 ZIPRASIDONE 1 0.0003
8 APREPITANT 2 0.0003
9 LAMIVUDINE 4 0.0002
See all drugs enriched for association with SUBMAXILLARY GLAND ENLARGEMENT